Amy J Grizzle

Summary

Affiliation: University of Arizona
Country: USA

Publications

  1. ncbi request reprint Reasons provided by prescribers when overriding drug-drug interaction alerts
    Amy J Grizzle
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ 85721 0202, USA
    Am J Manag Care 13:573-8. 2007
  2. ncbi request reprint Potential drug-drug interactions within Veterans Affairs medical centers
    Maysaa Mahmood
    Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona UA, Tucson, AZ 85721 0202, USA
    Am J Health Syst Pharm 64:1500-5. 2007
  3. doi request reprint Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation
    Lisa E Hines
    The Center for Health Outcomes and PharmacoEconomic Research, University of Arizona College of Pharmacy, 1295 N Martin Avenue, PO Box 210202, Tucson, AZ 85721 0202, USA
    Res Social Adm Pharm 7:359-68. 2011
  4. ncbi request reprint Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions
    Daniel C Malone
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, PO Box 210207, Tucson, AZ 85721 0207, USA
    J Am Pharm Assoc (2003) 44:142-51. 2004
  5. ncbi request reprint Workload and availability of technology in metropolitan community pharmacies
    Grant H Skrepnek
    Center for Health Outcomes and PharmarcoEconomic Research, College of Pharmacy, University of Arizona, 1703 East Mabel Street, Tucson, AZ 85721, USA
    J Am Pharm Assoc (2003) 46:154-60. 2006
  6. ncbi request reprint Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions
    Daniel C Malone
    College of Pharmacy, University of Arizona, Tucson 85721, USA
    Med Care 45:456-62. 2007
  7. doi request reprint Assessment tool for pharmacy drug-drug interaction software
    Terri L Warholak
    College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
    J Am Pharm Assoc (2003) 51:418-24. 2011
  8. ncbi request reprint Community pharmacy managers' perception of computerized drug-drug interaction alerts
    Jacob Abarca
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, P O Box 210207, Tucson, AZ 85721 0207, USA
    J Am Pharm Assoc (2003) 46:148-53. 2006
  9. doi request reprint Development of computerized alerts with management strategies for 25 serious drug-drug interactions
    John E Murphy
    College of Pharmacy, The University of Arizona, Tucson, AZ 85721 0202, USA
    Am J Health Syst Pharm 66:38-44. 2009
  10. pmc Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions
    Kim R Saverno
    Department of Pharmacy Practice and Science, The University of Arizona College of Pharmacy, Tucson, Arizona 85721 0202, USA
    J Am Med Inform Assoc 18:32-7. 2011

Detail Information

Publications14

  1. ncbi request reprint Reasons provided by prescribers when overriding drug-drug interaction alerts
    Amy J Grizzle
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ 85721 0202, USA
    Am J Manag Care 13:573-8. 2007
    ..To investigate prescribers' rationales for overriding drug-drug interaction (DDI) alerts and to determine whether these reasons were helpful to pharmacists as a part of prescription order verification...
  2. ncbi request reprint Potential drug-drug interactions within Veterans Affairs medical centers
    Maysaa Mahmood
    Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona UA, Tucson, AZ 85721 0202, USA
    Am J Health Syst Pharm 64:1500-5. 2007
    ..This study assessed the prevalence of 25 clinically important drug-drug interactions (DDIs) in the ambulatory care clinics of the Department of Veterans Affairs medical centers (VAMCs)...
  3. doi request reprint Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation
    Lisa E Hines
    The Center for Health Outcomes and PharmacoEconomic Research, University of Arizona College of Pharmacy, 1295 N Martin Avenue, PO Box 210202, Tucson, AZ 85721 0202, USA
    Res Social Adm Pharm 7:359-68. 2011
    ....
  4. ncbi request reprint Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions
    Daniel C Malone
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, PO Box 210207, Tucson, AZ 85721 0207, USA
    J Am Pharm Assoc (2003) 44:142-51. 2004
    ..To develop a list of clinically important drug-drug interactions (DDIs) likely to be encountered in community and ambulatory pharmacy settings and detected by a computerized pharmacy system...
  5. ncbi request reprint Workload and availability of technology in metropolitan community pharmacies
    Grant H Skrepnek
    Center for Health Outcomes and PharmarcoEconomic Research, College of Pharmacy, University of Arizona, 1703 East Mabel Street, Tucson, AZ 85721, USA
    J Am Pharm Assoc (2003) 46:154-60. 2006
    ..To assess workload characteristics and the presence of prescription processing technologies within metropolitan community pharmacies in the United States...
  6. ncbi request reprint Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions
    Daniel C Malone
    College of Pharmacy, University of Arizona, Tucson 85721, USA
    Med Care 45:456-62. 2007
    ..The purpose of this study was to examine pharmacy characteristics that may be associated with dispensed potential DDIs...
  7. doi request reprint Assessment tool for pharmacy drug-drug interaction software
    Terri L Warholak
    College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
    J Am Pharm Assoc (2003) 51:418-24. 2011
    ..To assess the performance of pharmacy clinical decision support (CDS) systems for drug-drug interaction (DDI) detection and to identify approaches for improving the ability to recognize important DDIs...
  8. ncbi request reprint Community pharmacy managers' perception of computerized drug-drug interaction alerts
    Jacob Abarca
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, P O Box 210207, Tucson, AZ 85721 0207, USA
    J Am Pharm Assoc (2003) 46:148-53. 2006
    ..To examine community pharmacists' attitudes toward computerized drug-drug interaction (DDI) alerts and identify factors associated with more favorable perceptions of these alerts...
  9. doi request reprint Development of computerized alerts with management strategies for 25 serious drug-drug interactions
    John E Murphy
    College of Pharmacy, The University of Arizona, Tucson, AZ 85721 0202, USA
    Am J Health Syst Pharm 66:38-44. 2009
    ..The development of computerized alerts with management strategies for 25 drug-drug interactions (DDIs) is described...
  10. pmc Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions
    Kim R Saverno
    Department of Pharmacy Practice and Science, The University of Arizona College of Pharmacy, Tucson, Arizona 85721 0202, USA
    J Am Med Inform Assoc 18:32-7. 2011
    ..However, studies indicate these systems may miss some important interactions. The purpose of this study was to assess the performance of pharmacy CDS programs to detect clinically important DDIs...
  11. ncbi request reprint Industry's perception of presenting pharmacoeconomic models to managed care organizations
    Bridget M Olson
    University of Arizona College of Pharmacy, 1703 East Mabel St, Room 318, PO Box 210207, Tucson, AZ 85721, USA
    J Manag Care Pharm 9:159-67. 2003
    ..Previous research has shown that pharmacoeconomic (PE) data are considered important but may not be optimally utilized by decision makers. No research has compared the effectiveness of different types of PE models...
  12. ncbi request reprint Longitudinal analysis of the use of etanercept versus infliximab determined from medical chart audit
    Jacob Abarca
    University of Arizona College of Pharmacy, Center for Health Outcomes and PharmacoEconomic Research, 1703 E Mabel, P O Box 210207, Tucson, AZ 85721 0207, USA
    J Manag Care Pharm 10:538-42. 2004
    ..To describe the dosing of etanercept and infliximab for the treatment of rheumatoid arthritis (RA)...
  13. ncbi request reprint Concordance of severity ratings provided in four drug interaction compendia
    Jacob Abarca
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson 85721 0207, USA
    J Am Pharm Assoc (2003) 44:136-41. 2004
    ..To evaluate the agreement among drug-drug interaction (DDI) compendia as to designation of interactions as having the greatest clinical importance ("major" DDIs)...
  14. doi request reprint Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review
    Eleanor L Olvey
    University of Arizona College of Pharmacy, Tucson, Arizona 85721 0202, USA
    Clin Ther 32:2282-303. 2010
    ..Treatments targeted at reducing this spasticity have evolved over time...